Asia Pacific Poc Diagnostics Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

POC diagnostics enable clinicians to obtain test results within minutes at the site of patient care, reducing reliance on centralized laboratory workflows. Within Asia Pacific, the market is one of the fastest-growing regional segments of the global POC diagnostics industry, which is itself valued in the tens of billions of dollars. Demand is strongest in densely populated markets such as China, India, Japan, and Southeast Asia, where decentralized testing can ease pressure on hospital laboratories.

• •Asia Pacific market valued at approximately USD 11.15 billion in 2025.
• •Projected to reach roughly USD 16.73 billion by 2030 at an 8.4% CAGR.
• •Among the highest-growth regional segments of the global POC diagnostics market.

Rising prevalence of diabetes, cardiovascular disease, and infectious illnesses is increasing the need for fast, routine testing outside of hospital labs. Government efforts to expand universal health coverage and rural screening programs in China, India, and ASEAN countries are accelerating device deployments. Technological advances in microfluidics, lateral flow assays, and portable molecular platforms are also broadening the menu of conditions that can be tested at the point of care.

• •Growing chronic disease burden across China, India, and Southeast Asia.
• •Public investment in primary care and decentralized testing infrastructure.
• •Improved accuracy and multiplexing capability of modern POC platforms.

The market spans multiple product categories including glucose monitoring, infectious disease testing, cardiac markers, coagulation, pregnancy and fertility tests, and hematology, alongside emerging molecular POC platforms. Glucose monitoring traditionally holds the largest share, while infectious disease and molecular segments are expanding most rapidly. Within Asia Pacific, China is widely identified as the fastest-growing national market, followed by India and Southeast Asia, with Japan and Australia contributing more mature, replacement-driven demand.

• •Glucose monitoring leads current revenue; infectious disease and molecular POC are the fastest-growing segments.
• •China is the top growth market, with India and ASEAN countries also expanding rapidly.
• •Japan and Australia represent more mature, technology-refresh-driven markets.

What are the recent trends and outlook?

Key trends shaping the outlook include the rise of connected POC devices that integrate with hospital information systems, the expansion of molecular POC testing for respiratory and sexually transmitted infections, and growing pharmacy- and home-based testing. AI-assisted result interpretation and cloud-based data management are beginning to appear in newer platforms. Through 2030, sustained double-digit growth in molecular segments and broader at-home testing are expected to keep Asia Pacific among the most dynamic regions for POC diagnostics worldwide.

• •Connected and cloud-linked POC devices are gaining traction across hospitals and retail pharmacies.
• •Molecular POC is the fastest-advancing technology segment, particularly for infectious disease testing.
• •Home-use and over-the-counter testing kits are expanding rapidly across major Asian consumer markets.